References

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

10.1016/s1474-4422(14)70267-4 · 2015 · External reference

Multiple sclerosis genetics

10.1016/s1474-4422(14)70041-9 · 2014 · External reference

Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy

2017 · External reference

Migraine headache in Multiple Sclerosis. Is more frequent among MS patients?

10.37897/rjn.2023.1.9 · 2023 · External reference

Classification, diagnosis, and differential diagnosis of multiple sclerosis

10.1097/wco.0000000000000206 · 2015 · External reference

Diagnosis and Management of Progressive Multiple Sclerosis

10.3390/biomedicines7030056 · 2019 · External reference

Primary progressive multiple sclerosis

10.1097/01.wco.0000169742.37159.e9 · 2005 · External reference

Diagnosis and management of secondary-progressive multiple sclerosis: time for change

10.2217/nmt-2019-0024 · 2019 · External reference

Multiple challenges for people after transitioning to secondary progressive multiple sclerosis: a qualitative study

10.1136/bmjopen-2018-026421 · 2019 · External reference

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review

10.3389/fneur.2021.666868 · 2021 · External reference

Predicting risk of secondary progression in multiple sclerosis: A nomogram

10.1177/1352458518783667 · 2019 · External reference

Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis

10.1016/s1474-4422(14)70250-9 · 2015 · External reference

Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?

10.1007/s11910-020-01045-3 · 2020 · External reference

The role of speed versus working memory in predicting learning new information in multiple sclerosis

10.1080/13803395.2012.760537 · 2013 · External reference

Examining the link between information processing speed and executive functioning in multiple sclerosis

10.1093/arclin/acp007 · 2009 · External reference

The relationship between executive functioning, processing speed, and white matter integrity in multiple sclerosis

10.1080/13803395.2013.806649 · 2013 · External reference

Difficulties in planning among patients with multiple sclerosis: a relative consequence of deficits in information processing speed

10.1017/s1355617713000155 · 2013 · External reference

Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights

10.1111/bpa.12220 · 2015 · External reference

Multiple sclerosis and cognition: synaptic failure and network dysfunction

10.1038/s41583-018-0053-9 · 2018 · External reference

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

10.1016/s1474-4422(21)00095-8 · 2021 · External reference

Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis

10.1191/1352458504ms1112oa · 2004 · External reference

Magnetic resonance imaging in multiple sclerosis—patients’ experiences, information interests and responses to an education programme

10.1371/journal.pone.0113252 · 2014 · External reference

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

10.1016/s1474-4422(17)30470-2 · 2018 · External reference

Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis

10.3174/ajnr.a3086 · 2012 · External reference

Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron

10.1136/jnnp-2014-307712 · 2014 · External reference

Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline

10.1002/hbm.22332 · 2014 · External reference

What explains gray matter atrophy in long-standing multiple sclerosis?

10.1148/radiol.14132708 · 2014 · External reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

10.1016/j.jclinepi.2009.06.005 · 2009 · External reference

Unresolved reference

2013 · External reference

Unresolved reference

2020 · External reference

Unresolved reference

2014 · External reference

Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis

10.1177/1352458513475490 · 2013 · External reference

Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study

10.1002/brb3.934 · 2018 · External reference

Cortical involvement determines impairment 30 years after a clinically isolated syndrome

10.1093/brain/awab033 · 2021 · External reference

Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI

10.1148/radiol.2019181719 · 2019 · External reference

The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis

10.3174/ajnr.a6513 · 2020 · External reference

A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis

10.1002/ana.21906 · 2010 · External reference

Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imaging

10.1177/1352458517726382 · 2018 · External reference

Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis

10.1212/wnl.0000000000011494 · 2021 · External reference

Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort

10.1111/ene.15098 · 2021 · External reference

Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression

10.1111/ene.13183 · 2017 · External reference

Deep gray matter volume loss drives disability worsening in multiple sclerosis

10.1002/ana.25145 · 2018 · External reference

Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis

10.1177/1352458510391342 · 2011 · External reference

Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosis

2022 · External reference

Brain atrophy and lesion load predict long term disability in multiple sclerosis

10.1136/jnnp-2012-304094 · 2013 · External reference

Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study

10.1016/j.jns.2011.11.040 · 2012 · External reference

Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression

10.1212/nxi.0000000000001139 · 2022 · External reference

T2 lesions and rate of progression of disability in multiple sclerosis

10.1111/j.1468-1331.2010.03093.x · 2010 · External reference

Streamline density and lesion volume reveal a postero-anterior gradient of corpus callosum damage in multiple sclerosis

10.1111/ene.14214 · 2020 · External reference

Pathological cut-offs of global and regional brain volume loss in multiple sclerosis

10.1177/1352458517742739 · 2019 · External reference

Thalamic nuclei degeneration in multiple sclerosis

10.1016/j.jocn.2021.05.043 · 2021 · External reference

Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease

10.1002/ana.25150 · 2018 · External reference

Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis

10.1007/s00415-020-09740-4 · 2020 · External reference

Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis

10.3174/ajnr.a5166 · 2017 · External reference

Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder

10.1111/ene.14038 · 2020 · External reference

Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes

10.1016/j.msard.2014.11.002 · 2015 · External reference

Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis

10.1148/radiol.2020200430 · 2020 · External reference

Spinal cord volume loss: A marker of disease progression in multiple sclerosis

10.1212/wnl.0000000000005853 · 2018 · External reference

Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis

10.1136/jnnp-2014-308021 · 2015 · External reference

Preferential spinal cord volume loss in primary progressive multiple sclerosis

10.1177/1352458518775006 · 2019 · External reference

Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis

10.1111/jon.12527 · 2018 · External reference

The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis

10.1212/wnl.0000000000005685 · 2018 · External reference

Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI

10.1093/brain/awaa436 · 2021 · External reference

A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis

10.1007/s00415-019-09643-z · 2020 · External reference

Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis

10.1136/jnnp.2009.199968 · 2010 · External reference

Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

10.12659/msm.903234 · 2017 · External reference

Corpus callosum index and long-term disability in multiple sclerosis patients

10.1007/s00415-010-5503-x · 2010 · External reference

Thalamic damage and long-term progression of disability in multiple sclerosis

10.1148/radiol.10100326 · 2010 · External reference

Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis

10.3390/jcm9051326 · 2020 · External reference

Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis

10.1002/ana.26281 · 2022 · External reference

Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes

10.1136/jnnp-2012-303821 · 2013 · External reference

Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis

10.1177/1352458516674567 · 2017 · External reference

Regional Cerebellar Volume Loss Predicts Future Disability in Multiple Sclerosis Patients

10.1007/s12311-021-01312-0 · 2022 · External reference

Evaluation of patients with multiple sclerosis using a combination of morphometrical features and clinical scores

10.1016/j.jocn.2009.04.023 · 2010 · External reference

Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis

10.1136/jnnp.2009.177733 · 2010 · External reference

MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis

10.1177/1352458515594043 · 2016 · External reference

Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study

2018 · External reference

Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus

10.1007/s00415-015-7763-y · 2015 · External reference

Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis

10.1016/j.nicl.2015.02.023 · 2015 · External reference

Limbic system damage in MS: MRI assessment and correlations with clinical testing

10.1371/journal.pone.0187915 · 2017 · External reference

Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis

10.1177/1352458515604905 · 2016 · External reference

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome

10.1002/ana.24564 · 2016 · External reference

Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial

10.1111/ene.15157 · 2022 · External reference

Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis

10.1177/1352458512442756 · 2012 · External reference

Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data

10.1177/1352458510394454 · 2011 · External reference

Predictive MRI Biomarkers in MS-A Critical Review

2022 · External reference

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study

10.1093/brain/awh498 · 2005 · External reference

Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis

10.1111/jon.12271 · 2016 · External reference

Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis—a two-year longitudinal MRI/MRSI study of corpus callosum

10.1177/1352458506071215 · 2007 · External reference

Reliability of brain volume measurements: a test-retest dataset

10.1038/sdata.2014.37 · 2014 · External reference

Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis

10.1016/j.neuroimage.2016.07.035 · 2016 · External reference

Critical analysis on the present methods for brain volume measurements in multiple sclerosis

10.1590/0004-282x20170072 · 2017 · External reference

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes

10.1177/1352458512473190 · 2013 · External reference

Brain MRI atrophy quantification in MS: From methods to clinical application

10.1212/wnl.0000000000003542 · 2017 · External reference

Brain atrophy measurements should be used to guide therapy monitoring in MS—NO

10.1177/1352458516649452 · 2016 · External reference

Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta-Analysis

10.1111/jon.12553 · 2018 · External reference

Cortical lesions and cognitive impairment in multiple sclerosis

10.1007/s10072-010-0368-4 · 2010 · External reference

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

10.1093/brain/awq118 · 2010 · External reference

Cortical lesion load associates with progression of disability in multiple sclerosis

10.1093/brain/aws246 · 2012 · External reference